GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (OTCPK:BOIRF) » Definitions » Profitability Rank

Boiron (Boiron) Profitability Rank : 7 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Boiron Profitability Rank?

Boiron has the Profitability Rank of 7.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Boiron's Operating Margin % for the quarter that ended in Dec. 2023 was 11.01%. As of today, Boiron's Piotroski F-Score is 6.


Competitive Comparison of Boiron's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boiron's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Boiron's Profitability Rank falls into.



Boiron Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Boiron has the Profitability Rank of 7.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Boiron's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=30.433 / 276.296
=11.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Boiron has an F-score of 6 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Boiron SA operating margin has been in a 5-year decline. The average rate of decline per year is -12.1%.

4. Consistency of the profitability

5. Predictability Rank


Boiron Profitability Rank Related Terms

Thank you for viewing the detailed overview of Boiron's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Boiron (Boiron) Business Description

Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron (Boiron) Headlines

From GuruFocus

The Fastest Share Repurchasing Companies in Europe

By Holly LaFon Holly LaFon 07-04-2014